Global Healthcare Industry M&A and Capital Market Landscape Q3’24 Review

This document is a report on the global healthcare industry, focusing on mergers and acquisitions (M&A) and capital market activities for the third quarter of 2024. It outlines the trends observed in healthcare M&A year-to-date, noting a broad-based deal activity driven by accessible capital and strategic negotiations. The report details the impact of geopolitical uncertainties and regulatory pressures on deal-making, as well as the cautious approach of sponsors amidst changing market conditions. Additionally, it highlights the resurgence of traditional initial public offerings and the role of environmental, social, and governance (ESG) factors in shaping investment strategies. The report also discusses the outlook for the fourth quarter of 2024, emphasizing the anticipated increase in deal activity, particularly in the pharmaceuticals and biotech sectors, as companies seek to transform their business models and replenish drug pipelines. The analysis includes insights into funding trends and the evolving landscape of SPACs in healthcare.